A Combination of Cytokines Rescues Highly Purified Leukemic CLL B-Cells from Spontaneous Apoptosis In Vitro

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Ghamlouch, Hussein ^a   Ouled Haddou, Hakim ^a   Damaj, Gandhi ^a,b   Royer, Bruno ^a,b   Gubler, Brigitte ^a,b   Marolleau, Jean Pierre ^a,b  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; B LYMPHOCYTE RECEPTOR; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 6;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CELL GROWTH; CELL SURVIVAL; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IN VITRO STUDY; MALE; PARACRINE SIGNALING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

AGED; AGED, 80 AND OVER; APOPTOSIS; B-LYMPHOCYTES; CELL SEPARATION; CELL SURVIVAL; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-4; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 84875456366     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060370     Document Type: Article

References (40)

1. Messmer BT, Messmer D, Allen SL, Kolitz JE, Kudalkar P, et al. (2005) In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 115: 755-764.
2. Ghia P, Chiorazzi N, Stamatopoulos K, (2008) Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med 264: 549-562.
3. Huh YO, Keating MJ, Saffer HL, Jilani I, Lerner S, et al. (2001) Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia. Am J Clin Pathol 116: 437-443.
4. Nadkarni JJ, Perambakam SM, Rathore VB, Amin KM, Parikh PM, et al. (1998) Expression of adhesion molecules in B-cell chronic lymphocytic leukaemia: an analysis in lymphoid compartments--peripheral blood, bone marrow and lymph node. Cancer Biother Radiopharm 13: 269-274.
5. Patten PE, Buggins AG, Richards J, Wotherspoon A, Salisbury J, et al. (2008) CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood 111: 5173-5181.
6. Smit LA, Hallaert DY, Spijker R, de Goeij B, Jaspers A, et al. (2007) Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity. Blood 109: 1660-1668.
7. Klein U, Dalla-Favera R, (2008) Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8: 22-33.
8. Plander M, Seegers S, Ugocsai P, Diermeier-Daucher S, Ivanyi J, et al. (2009) Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles. Leukemia 23: 2118-2128.
9. Munk Pedersen I, Reed J, (2004) Microenvironmental interactions and survival of CLL B-cells. Leuk Lymphoma 45: 2365-2372.
10. Yan XJ, Dozmorov I, Li W, Yancopoulos S, Sison C, et al. (2011) Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia. Blood 118: 5201-5210.
11. Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell'Aquila M, et al. (2000) Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96: 2655-2663.
12. Panayiotidis P, Jones D, Ganeshaguru K, Foroni L, Hoffbrand AV, (1996) Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol 92: 97-103.
13. Kay NE, Shanafelt TD, Strege AK, Lee YK, Bone ND, et al. (2007) Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch". Leuk Res 31: 899-906.
14. Granziero L, Ghia P, Circosta P, Gottardi D, Strola G, et al. (2001) Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood 97: 2777-2783.
15. Bagnara D, Kaufman MS, Calissano C, Marsilio S, Patten PE, et al. (2011) A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood 117: 5463-5472.
16. Pedersen IM, Kitada S, Leoni LM, Zapata JM, Karras JG, et al. (2002) Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 100: 1795-1801.
17. Gamberale R, Geffner J, Arrosagaray G, Scolnik M, Salamone G, et al. (2001) Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis. Leukemia 15: 1860-1867.
18. Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, et al. (2004) Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103: 679-688.
19. Nishio M, Endo T, Tsukada N, Ohata J, Kitada S, et al. (2005) Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106: 1012-1020.
20. Ostanin AA, Petrovskii YL, Shevela EY, Chernykh ER, (2011) Multiplex analysis of cytokines, chemokines, growth factors, MMP-9 and TIMP-1 produced by human bone marrow, adipose tissue, and placental mesenchymal stromal cells. Bull Exp Biol Med 151: 133-141.
21. Fluckiger AC, Garrone P, Durand I, Galizzi JP, Banchereau J, (1993) Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med 178: 1473-1481.
22. Decker T, Bogner C, Oelsner M, Peschel C, Ringshausen I, (2010) Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors. Ann Hematol 89: 1125-1132.
23. Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, et al. (1992) Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 176: 1319-1326.
24. Ma J, Ma D, Ji C, (2011) The role of IL-21 in hematological malignancies. Cytokine 56: 133-139.
25. Schuhknecht S, Duensing S, Dallmann I, Grosse J, Reitz M, et al. (2002) Interleukin-12 inhibits apoptosis in chronic lymphatic leukemia (CLL) B cells. Cancer Biother Radiopharm 17: 495-499.
26. Trentin L, Cerutti A, Zambello R, Sancretta R, Tassinari C, et al. (1996) Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood 87: 3327-3335.
27. de Totero D, Meazza R, Capaia M, Fabbi M, Azzarone B, et al. (2008) The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways. Blood 111: 517-524.
28. Wickremasinghe RG, Ganeshaguru K, Jones DT, Lindsay C, Spanswick VJ, et al. (2001) Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. Br J Haematol 114: 608-615.
29. Bomstein Y, Yuklea M, Radnay J, Shapiro H, Afanasyev F, et al. (2003) The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia. Eur J Haematol 70: 290-295.
30. Caligaris-Cappio F, Ghia P, (2007) The normal counterpart to the chronic lymphocytic leukemia B cell. Best Pract Res Clin Haematol 20: 385-397.
31. Krysov S, Dias S, Paterson A, Mockridge CI, Potter KN, et al. (2012) Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells. Blood 119: 170-179.
32. Zolnierczyk JD, Komina O, Blonski JZ, Borowiak A, Cebula-Obrzut B, et al. (2011) Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment. Med Oncol.
33. Burger JA, (2010) Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targeting. Semin Cancer Biol 20: 424-430.
34. Barragan M, Campas C, Bellosillo B, Gil J, (2003) Protein kinases in the regulation of apoptosis in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 44: 1865-1870.
35. Barragan M, Bellosillo B, Campas C, Colomer D, Pons G, et al. (2002) Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. Blood 99: 2969-2976.
36. Levesque MC, Chen Y, Beasley BE, O'Loughlin CW, Gockerman JP, et al. (2006) Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels. Leuk Res 30: 24-28.
37. Molica S, Digiesi G, Battaglia C, Cutrona G, Antenucci A, et al. (2010) Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia. Eur J Haematol 85: 314-320.
38. Tecchio C, Nichele I, Mosna F, Zampieri F, Leso A, et al. (2011) A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia. Eur J Haematol 87: 228-234.
39. Kamdje AH, Bassi G, Pacelli L, Malpeli G, Amati E, et al. (2012) Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy. Blood Cancer J 2: e73.
40. Kater AP, van Oers MH, Kipps TJ, (2007) Cellular immune therapy for chronic lymphocytic leukemia. Blood 110: 2811-2818.